Complete response letter received from FDA

6 October 2021 - Requirement to address approvability issues identified by FDA ahead of NDA resubmission ...

Read more →

Pillar Biosciences receives premarket approval from FDA for its oncoReveal Dx lung and colon cancer assay

5 August 2021 - Pillar Biosciences today announced the U.S. FDA has given premarket approval to its oncoReveal Dx Lung ...

Read more →

Foundation Medicine expands indication for FoundationOne Liquid CDx to be used as a companion diagnostic for Tabrecta (capmatinib)

15 July 2021 - Tabrecta is the first FDA approved MET inhibitor for patients with metastatic non-small cell lung cancer with ...

Read more →

Sonic Healthcare USA to offer assay to aid in the selection of Jemperli (dostarlimab-gxly) therapy in endometrial cancer

2 July 2021 - LMC Pathology Services, a Sonic Healthcare USA Anatomic Pathology Practice, is the first reference laboratory in ...

Read more →

FoundationOne CDx receives FDA approval as a companion diagnostic for Alunbrig (brigatinib) to identify patients with ALK positive metastatic non-small cell lung cancer

1 July 2021 - Foundation Medicine today announced that it has received approval from the U.S. FDA for FoundationOne CDx to ...

Read more →

Lantheus receives U.S. FDA approval of Pylarify (piflufolastat F 18) injection, the first and only commercially available PSMA PET imaging agent for prostate cancer

27 May 2021 - Pylarify will be available immediately to imaging centres in parts of the mid-Atlantic and southern regions and ...

Read more →

Illuminare-1, a novel nerve visualisation investigational fluorophore, granted fast track designation by U.S. FDA

25 May 2021 - Illuminare Biotechnologies announced that its novel nerve imaging agent, Illuminare-1, has been granted fast track designation by ...

Read more →

Alume Biosciences granted FDA fast track designation of ALM-488 for surgical nerve visualisation

12 May 2021 - Fast track designation highlights the urgent need for improved intra-operative nerve identification. ...

Read more →

Viome receives FDA approval for its unique mRNA technology and AI platform to detect cancers

6 May 2021 - FDA breakthrough designation validates Viome's proprietary mRNA analysing technology and state of the art AI platform to ...

Read more →

Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy

23 April 2021 - VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the ...

Read more →

Amgen launches Biomarker Assist, a program to help more patients with non-small cell lung cancer gain access to biomarker testing

19 April 2021 - Half of all patients with non-small cell lung cancer have oncogene mutations, yet many patients are not ...

Read more →

Biocartis announces US FDA 510(k) submission of its Idylla MSI test

20 April 2021 - First US FDA oncology assay submission for Biocartis. ...

Read more →

Amazon gets emergency FDA approval for at-home COVID-19 test kit

26 March 2021 - Amazon on Friday received emergency use authorisation from the FDA for an at-home COVID-19 testing kit that ...

Read more →

FDA authorises LetsGetChecked’s home collection coronavirus (COVID-19) test for direct to consumer purchase

24 March 2021 - The direct to consumer test is now authorised by the FDA to sell directly to consumers online ...

Read more →

DoorDash launches on-demand delivery of COVID-19 PCR test collection kits through partnerships with Vault Health and Everlywell

22 March 2021 - New partnerships make same-day delivery of FDA authorised COVID-19 test collection kits widely available to consumers across ...

Read more →